Warren Eric insider trades
Warren Eric has filed 36 Form 4s with the SEC that we hold, for ESPR (Chief Commercial Officer) and Mineralys Therapeutics, Inc. (MLYS) (Chief Commercial Officer). Across all of them we count 1 purchase worth $7.5K and 30 sales worth $3.4M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($3.3M). The largest single trade was a sale of 104,124 shares of Mineralys Therapeutics, Inc. worth $2.7M, dated 2026-06-26. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-03-16 and the latest 2026-09-22.
ESPR
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-17 | S, sale reported on Form 4 | 196 | $1.2K | 2022-05-18 |
| 2022-06-17 | S, sale reported on Form 4 | 256 | $1.3K | 2022-06-21 |
| 2022-07-19 | S, sale reported on Form 4 | 431 | $2.8K | 2022-07-20 |
| 2022-08-17 | S, sale reported on Form 4 | 199 | $1.4K | 2022-08-18 |
| 2022-08-31 | P, purchase reported on Form 4 | 1,000 | $7.5K | 2022-08-31 |
| 2022-09-19 | S, sale reported on Form 4 | 255 | $1.8K | 2022-09-20 |
| 2022-10-18 | S, sale reported on Form 4 | 107 | $823 | 2022-10-19 |
| 2023-03-07 | S, sale reported on Form 4 | 5,090 | $25.8K | 2023-03-08 |
| 2023-03-17 | S, sale reported on Form 4 | 526 | $936 | 2023-03-20 |
| 2023-04-19 | S, sale reported on Form 4 | 115 | $147 | 2023-04-20 |
| 2023-05-17 | S, sale reported on Form 4 | 219 | $355 | 2023-05-18 |
| 2023-06-21 | S, sale reported on Form 4 | 603 | $892 | 2023-06-22 |
| 2023-07-19 | S, sale reported on Form 4 | 106 | $169 | 2023-07-20 |
| 2023-08-18 | S, sale reported on Form 4 | 243 | $343 | 2023-08-21 |
| 2023-09-20 | S, sale reported on Form 4 | 742 | $928 | 2023-09-21 |
| 2024-05-17 | S, sale reported on Form 4 | 192 | $476 | 2024-05-20 |
| 2024-06-18 | S, sale reported on Form 4 | 2,540 | $7.3K | 2024-06-20 |
| 2024-07-17 | S, sale reported on Form 4 | 108 | $280 | 2024-07-19 |
| 2024-08-19 | S, sale reported on Form 4 | 211 | $411 | 2024-08-20 |
| 2024-09-17 | S, sale reported on Form 4 | 2,608 | $4.6K | 2024-09-18 |
| 2024-10-17 | S, sale reported on Form 4 | 107 | $227 | 2024-10-18 |
| 2024-11-19 | S, sale reported on Form 4 | 197 | $427 | 2024-11-20 |
| 2024-12-17 | S, sale reported on Form 4 | 2,234 | $5.4K | 2024-12-18 |
| 2025-01-17 | S, sale reported on Form 4 | 123 | $278 | 2025-01-21 |
| 2025-02-19 | S, sale reported on Form 4 | 239 | $447 | 2025-02-20 |
| 2025-03-18 | S, sale reported on Form 4 | 2,433 | $3.6K | 2025-03-19 |
| 2025-04-17 | S, sale reported on Form 4 | 108 | $106 | 2025-04-21 |
Mineralys Therapeutics, Inc. (MLYS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-06-26 | S, sale reported on Form 4 | 104,124 | $2.7M | 2026-06-30 |
| 2026-07-21 | S, sale reported on Form 4 | 7,438 | $199.9K | 2026-07-23 |
| 2026-08-21 | S, sale reported on Form 4 | 7,437 | $193.2K | 2026-08-25 |
| 2026-09-21 | S, sale reported on Form 4 | 7,438 | $209.1K | 2026-09-22 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1916048) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms